AYALA PHARMACEUTICALS INC (AYLA) Stock Analyst Earnings Estimates
NASDAQ:AYLA - Nasdaq - US05465V1089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.33M | 3.71M 59.23% | 3.506M -5.50% | 2.04M -41.81% | 2.346M 15.00% | N/A | |
| EBITDA YoY % growth | -17.56M -95.33% | -29.6M -68.56% | -39.05M -31.93% | N/A | N/A | N/A | |
| EBIT YoY % growth | -17.71M -95.91% | -29.78M -68.15% | -39.218M -31.69% | -38.25M 2.47% | -33.456M 12.53% | N/A | |
| Operating Margin | -760.09% | -802.70% | -1,118.60% | -1,875.00% | -1,426.09% | N/A | |
| EPS YoY % growth | N/A | -3.38 | -2.83 16.27% | -2.73 3.59% | -2.34 14.21% | -3.57 -52.64% |
All data in USD
| Q4 / 22 | |
|---|---|
| EPS Q2Q % growth | -0.74 -12.82% |
| Revenue Q2Q % growth | 408K -64.40% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -12.342M -26.36% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.66 2.94% | -0.50 | -0.16 | -30.98% |
| Q2 2022 Q2Q % growth | -0.54 28.00% | -0.67 | 0.13 | 18.82% |
| Q1 2022 Q2Q % growth | -0.66 10.81% | -0.69 | 0.03 | 4.31% |
| Q4 2021 Q2Q % growth | -0.66 9.59% | -0.62 | -0.04 | -6.83% |
| Q3 2021 Q2Q % growth | -0.68 -15.25% | -0.81 | 0.13 | 16.25% |
| Q2 2021 Q2Q % growth | -0.75 -1.35% | -0.64 | -0.11 | -17.51% |
| Q1 2021 Q2Q % growth | -0.74 43.94% | -0.72 | -0.02 | -2.66% |
| Q4 2020 Q2Q % growth | -0.73 | -0.59 | -0.14 | -22.97% |
| Q3 2020 Q2Q % growth | -0.59 | -0.56 | -0.03 | -6.20% |
| Q2 2020 Q2Q % growth | -0.74 | -0.54 | -0.20 | -37.27% |
| Q1 2020 Q2Q % growth | -1.32 | -0.77 | -0.55 | -71.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 91K -85.44% | 632.4K | -541.4K | -85.61% |
| Q2 2022 Q2Q % growth | 38K -95.01% | 629.003K | -591.003K | -93.96% |
| Q1 2022 Q2Q % growth | 458K -52.78% | 846.6K | -388.6K | -45.90% |
| Q4 2021 Q2Q % growth | 1.146M 14.60% | 707.441K | 438.559K | 61.99% |
| Q3 2021 Q2Q % growth | 625K -5.30% | 856.8K | -231.8K | -27.05% |
| Q2 2021 Q2Q % growth | 761K -27.52% | 1.044M | -283K | -27.11% |
| Q1 2021 Q2Q % growth | 970K -3.00% | 1.326M | -356K | -26.85% |
| Q4 2020 Q2Q % growth | 1M | 547.403K | 452.597K | 82.68% |
| Q2 2020 Q2Q % growth | 1.05M | 425.003K | 624.997K | 147.06% |
| Q1 2020 Q2Q % growth | 1M 270.37% | 282.203K | 717.797K | 254.35% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -43.61% | 0% | -22.52% |
| Revenue | 0% | -42.86% | 0% | 15.43% |